Global Cardiac Mapping Market

Cardiac Mapping Market Size, Share, Growth Analysis, By End user(Hospitals & Clinics, Diagnostic Centers), By Product(Contact Cardiac Mapping Systems, and Non-Contact Cardiac Mapping Systems), By Indication(Atrial Fibrillation, Atrial Flutter) - Industry Forecast 2024-2031

Report ID: SQMIG35A2783 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 90 | Figures: 73

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Cardiac Mapping Market size was valued at USD 1.86 billion in 2022 and is poised to grow from USD 2.03 billion in 2023 to USD 4.01 billion by 2031, growing at a CAGR of 8.90% during the forecast period (2024-2031).

The competitive environment of the Cardiac Mapping market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Biosense Webster (U.S.)', 'Boston Scientific Corporation (U.S.)', 'Medtronic (Ireland)', 'Abbott (U.S.)', 'BIOTRONIK (Germany)', 'MicroPort Scientific Corporation (China)', 'Acutus Medical Inc. (U.S.)', 'Catheter Precision (U.S.)', 'Koninklijke Philips N.V. (Netherlands)', 'EP Solutions (Switzerland)', 'Lepu Medical Technology Co. Ltd. (China)', 'AngioDynamics (U.S.)', 'BioSig Technologies (U.S.)', 'APN Health (U.S.)', 'CoreMap (U.S.)', 'Kardium (Canada)', 'Epmap-System (Germany)'

The anticipated growth in market revenue for cardiac mapping systems is underpinned by two key factors: the rising likelihood of an increase in cardiovascular disorders and the continuous technological advancements in cardiac mapping diagnostics. According to the World Health Organisation (WHO), cardiovascular diseases (CVDs) stand as the leading cause of mortality, responsible for approximately 17.9 million deaths annually. Notably, more than four out of every five CVD-related fatalities are attributed to heart attacks and strokes, with a significant proportion occurring in individuals under the age of 70.

During the forecast period, the cardiac imaging market is expected to witness substantial growth driven by multiple factors. Medical device companies are expected to play a key role in this trend as cutting-edge diagnostic technologies are increasingly adopted. Increasing demand for accurate cardiac testing has been identified as another major driver The growth is great because of its expansion.

The North American cardiac mapping market is poised to assert its dominance, driven by several key factors. The region's leading position is attributed to the high prevalence of Cardiovascular Diseases (CVDs), a health concern that has prompted an increasing acceptance rate of cardiac mapping systems in the United States. The validation of these systems through clinical trials further contributes to the robust demand growth anticipated over the forecast period.

Related Reports

Sacroiliac Joint Fusion Market
Buy Now GET FREE SAMPLE
Non-Invasive Blood Glucose Monitoring System Market
Buy Now GET FREE SAMPLE
AI in Epidemiology Market
Buy Now GET FREE SAMPLE
Mammography Workstation Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Cardiac Mapping Market

Product ID: SQMIG35A2783

$5,300
BUY NOW GET FREE SAMPLE